Glyoxalase I Glu111Ala polymorphism in patients with breast cancer

Cancer Investigation

Volumn 27, Issue 6, 2009, Pages 655-660

  Germanová, Alexandra ^a   Germanová, Anna ^a   Tesarová, Petra ^a   Jáchymová, Marie ^a   Zvára, Karel ^b   Zima, Tomáš ^a   Kalousová, Marta ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF COMPUTER SCIENCE   (Czech Republic)

Author keywords

Advanced glycation end products; AGEs; Breast cancer; Glyoxalase I; Soluble receptor for advanced glycation end products; sRAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ESTROGEN RECEPTOR; LACTOYLGLUTATHIONE LYASE; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BLOOD; BREAST TUMOR; CANCER STAGING; CASE CONTROL STUDY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; PHENOTYPE; PROGNOSIS;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENOTYPE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LACTOYLGLUTATHIONE LYASE; MIDDLE AGED; NEOPLASM STAGING; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, IMMUNOLOGIC;

EID: 67649946183     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802350822     Document Type: Article

References (34)

1. Miyata, T.; Fu, M.; Kurokawa, K.; van Ypersele de Strihou, C.; Thorpe, S.; Baynes, J.W. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? Kidney Int 1998, 54, 1290-1295.
2. Evans, M.D.; Dizdaroglu, M.; Cooke, M.S. Oxidative DNA damage and disease: induction, repair, and significance. Mutat Res 2004, 567, 1-61. (Pubitemid 39162992)
3. Kang, D.; Hamasaki, N. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer. Curr Med Chem 2005, 12,429-441. (Pubitemid 40309137)
4. Beisswenger, P.J.; Howell, S.K.; Nelson, R.G.; Mauer, M.; Szwergold, B.S. α-oxoaldehyde metabolism and diabetic complications. Biochem Soc Trans 2003, 31, 1358-1363.
5. Kalousová, M.; Zima, T.; Tesał, V.; Dusilová- Sulková, S.; Škrha, J. Advanced glycoxidation end products in chronic diseases - clinical chemistry and genetic backround. Mutat Res 2005, 579, 37-46. (Pubitemid 41540131)
6. Bierhaus, A.; Hofmann, M.A.; Ziegler, R.A.; Nawroth, P.P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus I. The AGE concept. Cardiovasc Res 1998, 37, 586-600.
7. Kislinger, T.; Fu, C.; Huber, B.; Qu, W.; Taguchi, A.; Yan, S.D.; Hofmann, M.; Yan, S.F.; Pischetsrieder, M.; Stern, D.; Schmidt, A.M. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell-signaling pathway and modulate gene expression. J Biol Chem 1999, 274, 31740-31749. (Pubitemid 129501639)
8. Cengiz, K. Increased incidence of neoplasia in chronic renal failure (20 years experience). Int Urol Nephrol 2002, 33, 121-126.
9. Schmidt, A.M.; Yan, S.D.; Yan, S.F.; Stern, D.M. The biology of the receptor for advanced glycation end products and its ligands. Mol Cell Res 2000, 1489, 99-111.
10. Thornalley, P.J. Glyoxalase I - structure, function, and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 2003, 31,1343-1348.
11. Thornalley, P.J. The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J 1990, 269, 1-11.
12. Gale, C.P.; Grant, P.J. The characterization and functional analysis of the human glyoxalase I gene using methods of bioinformatics. Gene 2004, 340, 251-260. (Pubitemid 39314647)
13. Politi, P.; Minoretii, P.; Falcone, C.; Martinelli, V.; Emanuele, E. Association analysis of the functional Ala111Glu polymorphism of the glyoxalase I gene in panic disorder. Neurosci Lett 2006, 396, 163-166. (Pubitemid 43276433)
14. Gale, C.P.; Futers, T.S.; Summers, L.K. Common polymorphisms in the glyoxalase-1 gene and their association with prothrombotic factors. Diab Vasc Dis Res 2004, 1, 34-39.
15. Munch, G.; Keis, R.; Wessels, A.; Riederer, P.; Bahner, U.; Heidland, A.; Niwa, T.; Lemke H.D.; Schinzel, R. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 1997, 35, 669-677. (Pubitemid 27453364)
16. Henle, T.; Deppisch, R.; Beck, W.; Hergesell, O.; Hansch, G.M.; Ritz, E. Advanced glycated end-products (AGEs) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogenity of AGE compounds. Nephrol Dial Transplant 1999, 14, 1968-1975. (Pubitemid 29358896)
17. Haldane, J.B.S. An exact test for randomness of mating. J Genet 1954, 52, 631-635.
18. McCann, V.J.; Davis, R.E.; Welbourn, T.A.; Constable, J.; Beale, D.G. Glyoxalase phenotypes in patients with diabetes mellitus. Aust N Z J Med 1981, 11, 380-382. (Pubitemid 11022746)
19. Thornalley, P.J.; Hooper, N.I.; Jenning, P.E.; Florkowski, C.M.; Jones, A.M.; Lunec, J.; Barnett, A.H. The human red blood cell glyoxalase system in diabetes mellitus. Diab Res Clin Pract 1989, 7, 115-120. (Pubitemid 19221706)
20. Di Ilio, C.; Angelucci, S.; Pennelli, A.; Zezz, A.; Tenaglia, R.; Sacchetta, P. Glyoxalase activities in tumor and nontumor human urogenital tissues. Cancer Lett 1995, 96, 189-193.
21. Di Ilio, C.; Del Boccio, G.; Casaccia, R.; Aceto, A.; Di Giacom, F.; Federici, G. Selenium level and gluthatione activities in normal and neoplastic human lung tissues. Carcinogenesis 1987, 8, 281-284.
22. Antognelli, C.; Baldracchini, F.; Talesa, V.N.; Constantini, E.; Zucchi, A.; Mearini, E. Overexpression of glyoxalase system enzymes in human kidney tumor. Cancer J 2006, 12, 222-228. (Pubitemid 43894339)
23. Rangnathan, S.; Tew, K.D. Analysis of glyoxalase I from normal and tumor tissue from human colon. Biochim Biophys Acta 1993, 1182, 311-316. (Pubitemid 23310058)
24. Rulli, A.; Carli, L.; Romani, R.; Baroni, T.; Giovannini, E.; Rosi, G.; Talesa, V. Expression of glyoxalase I and II in normal and breast cancer tissues. Breast Cancer Res Treat 2001, 66, 67-72. (Pubitemid 32397944)
25. Okado, A.; Kawasaki, Y.; Hasuike, Y.; Takahashi, M.; Teshima, T.; Fujii, J.; Taniguchi, N. Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem Biophys Res Commun 1996, 225, 219-224. (Pubitemid 26285423)
26. Jones, M.B.; Krutzsch, H.; Shu, H.; Zhao, Y.; Liotta, L.A.; Kohn, E.C.; Petricoin, E.F., 3rd. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2002, 2, 76-84.
27. Zhang, D.; Tai, K.L.; Wong, L.L.; Chiu, L.; Sethi, S.K.; Koay, E.S.C. Proteomic study reveals that proteins involved in metabolic and detoxification pathway are highly expressed in Her-2/neu-positive breast cancer. Mol Cell Proteom 2005, 11, 1686-1696.
28. Kamiya, D.; Uchihata, Y.; Ichikawa, E.; Kato, K.; Umezawa, K. Reversal of anticancer drug resistance by COTC based on intracellular glutathione and glyoxalase I. Bioorg Med Chem Lett 2005, 15, 1111-1114. (Pubitemid 40458657)
29. Thornalley, P.J. Protecting the genome: defence against nucleotide glycation and emerging role of glyoxalase I overexpression in multidrug resistance in cancer chemotherpy. Biochem Soc Trans 2003, 31, 1372-1377.
30. Samadi, A.A.; Fullerton, S.A.; Tortorelis, D.G.; Johnson, G.B.; Davidson, S.D.; Choudhury, M.S.; Mallouh, C.; Tazaki, H.; Konno, S. Glyoxalase I phenotype as a potential risk factor for prostate carcinoma. Urology 2001, 57, 183-187. (Pubitemid 32065853)
31. Rulli, A.; Antognelli, C.; Prezzi, E.; Baldracchini, F.; Piva, F.; Giovanni E.; Talesa, V. A possible regulatory role of 17β-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells. Breast Cancer Res Treat 2006, 96, 187-196.
32. Tesařová, P.; Kalousová, M.; Trnková, B.; Soukupová, J.; Argalašová, S.; Mestek, O.; Petruželka, L.; Zima, T. Carbonyl and oxidative stress in patients with breast cancer is there a relation to the stage of the disease? Neoplasma 2007, 54, 219-224.
33. Tesařová, P.; Kalousová, M.; Jáchymová , M.; Mestek, O.; Petruželka, L.; Zima, T. Receptor for advanced glycation end products (RAGE)-soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Invest 2007, 25, 720-725. (Pubitemid 350223177)
34. Kobayashi, S.; Kubo, H.; Suzuki, T.; Ishizawa, K.; Yamada, M.; He, M.; Yamamoto, Y.; Yamamoto, H.; Sasano, H.; Sasaki, H.; Suzuki, S. Endogenous secretory receptor for advanced glycation end products in non-small-cell lung carcinoma. Am J Respir Crit Care Med 2007, 175, 184-189. (Pubitemid 46115090)